(MON)—The Bayer divestiture to satisfy antitrust regulators is in-line with my expectations. (From a tax standpoint, I'm happy that the deal is closing in 2018 rather than 2017.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.